TAKAYASU ARTERITIS
Clinical trials for TAKAYASU ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new TAKAYASU ARTERITIS trials appear
Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Surgery may boost survival in rare vascular disease
Disease control CompletedThis study looked back at 78 patients with severe Takayasu arteritis, a rare inflammatory disease that damages the body's largest arteries. Researchers compared whether surgery or medication alone led to better survival rates. The goal was to understand which approach helps patie…
Matched conditions: TAKAYASU ARTERITIS
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Alcoholism drug repurposed to fight pain and fatigue in rare autoimmune diseases
Symptom relief CompletedThis study tested whether a very low dose of an existing drug, naltrexone, could improve daily life for people with vasculitis, a group of rare autoimmune diseases that cause blood vessel inflammation. Sixty patients whose disease was stable but who still struggled with poor phys…
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC